Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Inactivated Vaccines market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Inactivated Vaccines market. Detailed analysis of key players, along with key growth strategies adopted by Inactivated Vaccines industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
MedImmune, LLC
Merck & Co
India Pvt Ltd (India)
Astellas Pharma Inc
Sanofi Pasteur
GlaxoSmithKline
Emergent BioSolutions, Inc
CSL Limited
India Pvt. Ltd. (India)
Serum Institute
Pfizer
By Type:
Pneumococcal
Influenza
HPV
Hepatitis
Rotavirus
DTP
Polio
MMR
By End-User:
Pediatric
Adult
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Inactivated Vaccines Market
-
1.3 Market Segment by Type
1.3.1 Japan Inactivated Vaccines Market Size and Growth Rate of Pneumococcal from 2014 to 2026
1.3.2 Japan Inactivated Vaccines Market Size and Growth Rate of Influenza from 2014 to 2026
1.3.3 Japan Inactivated Vaccines Market Size and Growth Rate of HPV from 2014 to 2026
1.3.4 Japan Inactivated Vaccines Market Size and Growth Rate of Hepatitis from 2014 to 2026
1.3.5 Japan Inactivated Vaccines Market Size and Growth Rate of Rotavirus from 2014 to 2026
1.3.6 Japan Inactivated Vaccines Market Size and Growth Rate of DTP from 2014 to 2026
1.3.7 Japan Inactivated Vaccines Market Size and Growth Rate of Polio from 2014 to 2026
1.3.8 Japan Inactivated Vaccines Market Size and Growth Rate of MMR from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Inactivated Vaccines Market Size and Growth Rate of Pediatric from 2014 to 2026
1.4.2 Japan Inactivated Vaccines Market Size and Growth Rate of Adult from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Inactivated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Inactivated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Inactivated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Inactivated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Inactivated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Inactivated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Inactivated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Inactivated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Inactivated Vaccines Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Inactivated Vaccines by Major Types
3.4.1 Market Size and Growth Rate of Pneumococcal
3.4.2 Market Size and Growth Rate of Influenza
3.4.3 Market Size and Growth Rate of HPV
3.4.4 Market Size and Growth Rate of Hepatitis
3.4.5 Market Size and Growth Rate of Rotavirus
3.4.6 Market Size and Growth Rate of DTP
3.4.7 Market Size and Growth Rate of Polio
3.4.8 Market Size and Growth Rate of MMR
4 Segmentation of Inactivated Vaccines Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Inactivated Vaccines by Major End-Users
4.4.1 Market Size and Growth Rate of Inactivated Vaccines in Pediatric
4.4.2 Market Size and Growth Rate of Inactivated Vaccines in Adult
5 Market Analysis by Regions
-
5.1 Japan Inactivated Vaccines Production Analysis by Regions
-
5.2 Japan Inactivated Vaccines Consumption Analysis by Regions
6 Hokkaido Inactivated Vaccines Landscape Analysis
-
6.1 Hokkaido Inactivated Vaccines Landscape Analysis by Major Types
-
6.2 Hokkaido Inactivated Vaccines Landscape Analysis by Major End-Users
7 Tohoku Inactivated Vaccines Landscape Analysis
-
7.1 Tohoku Inactivated Vaccines Landscape Analysis by Major Types
-
7.2 Tohoku Inactivated Vaccines Landscape Analysis by Major End-Users
8 Kanto Inactivated Vaccines Landscape Analysis
-
8.1 Kanto Inactivated Vaccines Landscape Analysis by Major Types
-
8.2 Kanto Inactivated Vaccines Landscape Analysis by Major End-Users
9 Chubu Inactivated Vaccines Landscape Analysis
-
9.1 Chubu Inactivated Vaccines Landscape Analysis by Major Types
-
9.2 Chubu Inactivated Vaccines Landscape Analysis by Major End-Users
10 Kinki Inactivated Vaccines Landscape Analysis
-
10.1 Kinki Inactivated Vaccines Landscape Analysis by Major Types
-
10.2 Kinki Inactivated Vaccines Landscape Analysis by Major End-Users
11 Chugoku Inactivated Vaccines Landscape Analysis
-
11.1 Chugoku Inactivated Vaccines Landscape Analysis by Major Types
-
11.2 Chugoku Inactivated Vaccines Landscape Analysis by Major End-Users
12 Shikoku Inactivated Vaccines Landscape Analysis
-
12.1 Shikoku Inactivated Vaccines Landscape Analysis by Major Types
-
12.2 Shikoku Inactivated Vaccines Landscape Analysis by Major End-Users
13 Kyushu Inactivated Vaccines Landscape Analysis
-
13.1 Kyushu Inactivated Vaccines Landscape Analysis by Major Types
-
13.2 Kyushu Inactivated Vaccines Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 MedImmune, LLC
14.1.1 MedImmune, LLC Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 Merck & Co
14.2.1 Merck & Co Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 India Pvt Ltd (India)
14.3.1 India Pvt Ltd (India) Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 Astellas Pharma Inc
14.4.1 Astellas Pharma Inc Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 Sanofi Pasteur
14.5.1 Sanofi Pasteur Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 GlaxoSmithKline
14.6.1 GlaxoSmithKline Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 Emergent BioSolutions, Inc
14.7.1 Emergent BioSolutions, Inc Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 CSL Limited
14.8.1 CSL Limited Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 India Pvt. Ltd. (India)
14.9.1 India Pvt. Ltd. (India) Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
14.10 Serum Institute
14.10.1 Serum Institute Company Profile and Recent Development
14.10.2 Market Performance
14.10.3 Product and Service Introduction
14.11 Pfizer
14.11.1 Pfizer Company Profile and Recent Development
14.11.2 Market Performance
14.11.3 Product and Service Introduction
The List of Tables and Figures (Totals 132 Figures and 123 Tables)
Figure Japan Inactivated Vaccines Market Size and Growth Rate of Pneumococcal from 2014 to 2026
Figure Japan Inactivated Vaccines Market Size and Growth Rate of Influenza from 2014 to 2026
Figure Japan Inactivated Vaccines Market Size and Growth Rate of HPV from 2014 to 2026
Figure Japan Inactivated Vaccines Market Size and Growth Rate of Hepatitis from 2014 to 2026
Figure Japan Inactivated Vaccines Market Size and Growth Rate of Rotavirus from 2014 to 2026
Figure Japan Inactivated Vaccines Market Size and Growth Rate of DTP from 2014 to 2026
Figure Japan Inactivated Vaccines Market Size and Growth Rate of Polio from 2014 to 2026
Figure Japan Inactivated Vaccines Market Size and Growth Rate of MMR from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Inactivated Vaccines Market Size and Growth Rate of Pediatric from 2014 to 2026
Figure Japan Inactivated Vaccines Market Size and Growth Rate of Adult from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Inactivated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Inactivated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Inactivated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Inactivated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Inactivated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Inactivated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Inactivated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Inactivated Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Inactivated Vaccines Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Inactivated Vaccines
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Inactivated Vaccines by Different Types from 2014 to 2026
-
Table Consumption Share of Inactivated Vaccines by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Pneumococcal
Figure Market Size and Growth Rate of Influenza
Figure Market Size and Growth Rate of HPV
Figure Market Size and Growth Rate of Hepatitis
Figure Market Size and Growth Rate of Rotavirus
Figure Market Size and Growth Rate of DTP
Figure Market Size and Growth Rate of Polio
Figure Market Size and Growth Rate of MMR
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Inactivated Vaccines by Different End-Users from 2014 to 2026
-
Table Consumption Share of Inactivated Vaccines by Different End-Users from 2014 to 2026
Figure Japan Inactivated Vaccines Market Size and Growth Rate of Pediatric from 2014 to 2026
Figure Japan Inactivated Vaccines Market Size and Growth Rate of Adult from 2014 to 2026
-
Table Japan Inactivated Vaccines Production by Regions
-
Table Japan Inactivated Vaccines Production Share by Regions
-
Figure Japan Inactivated Vaccines Production Share by Regions in 2014
-
Figure Japan Inactivated Vaccines Production Share by Regions in 2018
-
Figure Japan Inactivated Vaccines Production Share by Regions in 2026
-
Table Japan Inactivated Vaccines Consumption by Regions
-
Table Japan Inactivated Vaccines Consumption Share by Regions
-
Figure Japan Inactivated Vaccines Consumption Share by Regions in 2014
-
Figure Japan Inactivated Vaccines Consumption Share by Regions in 2018
-
Figure Japan Inactivated Vaccines Consumption Share by Regions in 2026
-
Table Hokkaido Inactivated Vaccines Consumption by Types from 2014 to 2026
-
Table Hokkaido Inactivated Vaccines Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Inactivated Vaccines Consumption Share by Types in 2014
-
Figure Hokkaido Inactivated Vaccines Consumption Share by Types in 2018
-
Figure Hokkaido Inactivated Vaccines Consumption Share by Types in 2026
-
Table Hokkaido Inactivated Vaccines Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Inactivated Vaccines Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Inactivated Vaccines Consumption Share by End-Users in 2014
-
Figure Hokkaido Inactivated Vaccines Consumption Share by End-Users in 2018
-
Figure Hokkaido Inactivated Vaccines Consumption Share by End-Users in 2026
-
Table Tohoku Inactivated Vaccines Consumption by Types from 2014 to 2026
-
Table Tohoku Inactivated Vaccines Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Inactivated Vaccines Consumption Share by Types in 2014
-
Figure Tohoku Inactivated Vaccines Consumption Share by Types in 2018
-
Figure Tohoku Inactivated Vaccines Consumption Share by Types in 2026
-
Table Tohoku Inactivated Vaccines Consumption by End-Users from 2014 to 2026
-
Table Tohoku Inactivated Vaccines Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Inactivated Vaccines Consumption Share by End-Users in 2014
-
Figure Tohoku Inactivated Vaccines Consumption Share by End-Users in 2018
-
Figure Tohoku Inactivated Vaccines Consumption Share by End-Users in 2026
-
Table Kanto Inactivated Vaccines Consumption by Types from 2014 to 2026
-
Table Kanto Inactivated Vaccines Consumption Share by Types from 2014 to 2026
-
Figure Kanto Inactivated Vaccines Consumption Share by Types in 2014
-
Figure Kanto Inactivated Vaccines Consumption Share by Types in 2018
-
Figure Kanto Inactivated Vaccines Consumption Share by Types in 2026
-
Table Kanto Inactivated Vaccines Consumption by End-Users from 2014 to 2026
-
Table Kanto Inactivated Vaccines Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Inactivated Vaccines Consumption Share by End-Users in 2014
-
Figure Kanto Inactivated Vaccines Consumption Share by End-Users in 2018
-
Figure Kanto Inactivated Vaccines Consumption Share by End-Users in 2026
-
Table Chubu Inactivated Vaccines Consumption by Types from 2014 to 2026
-
Table Chubu Inactivated Vaccines Consumption Share by Types from 2014 to 2026
-
Figure Chubu Inactivated Vaccines Consumption Share by Types in 2014
-
Figure Chubu Inactivated Vaccines Consumption Share by Types in 2018
-
Figure Chubu Inactivated Vaccines Consumption Share by Types in 2026
-
Table Chubu Inactivated Vaccines Consumption by End-Users from 2014 to 2026
-
Table Chubu Inactivated Vaccines Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Inactivated Vaccines Consumption Share by End-Users in 2014
-
Figure Chubu Inactivated Vaccines Consumption Share by End-Users in 2018
-
Figure Chubu Inactivated Vaccines Consumption Share by End-Users in 2026
-
Table Kinki Inactivated Vaccines Consumption by Types from 2014 to 2026
-
Table Kinki Inactivated Vaccines Consumption Share by Types from 2014 to 2026
-
Figure Kinki Inactivated Vaccines Consumption Share by Types in 2014
-
Figure Kinki Inactivated Vaccines Consumption Share by Types in 2018
-
Figure Kinki Inactivated Vaccines Consumption Share by Types in 2026
-
Table Kinki Inactivated Vaccines Consumption by End-Users from 2014 to 2026
-
Table Kinki Inactivated Vaccines Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Inactivated Vaccines Consumption Share by End-Users in 2014
-
Figure Kinki Inactivated Vaccines Consumption Share by End-Users in 2018
-
Figure Kinki Inactivated Vaccines Consumption Share by End-Users in 2026
-
Table Chugoku Inactivated Vaccines Consumption by Types from 2014 to 2026
-
Table Chugoku Inactivated Vaccines Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Inactivated Vaccines Consumption Share by Types in 2014
-
Figure Chugoku Inactivated Vaccines Consumption Share by Types in 2018
-
Figure Chugoku Inactivated Vaccines Consumption Share by Types in 2026
-
Table Chugoku Inactivated Vaccines Consumption by End-Users from 2014 to 2026
-
Table Chugoku Inactivated Vaccines Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Inactivated Vaccines Consumption Share by End-Users in 2014
-
Figure Chugoku Inactivated Vaccines Consumption Share by End-Users in 2018
-
Figure Chugoku Inactivated Vaccines Consumption Share by End-Users in 2026
-
Table Shikoku Inactivated Vaccines Consumption by Types from 2014 to 2026
-
Table Shikoku Inactivated Vaccines Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Inactivated Vaccines Consumption Share by Types in 2014
-
Figure Shikoku Inactivated Vaccines Consumption Share by Types in 2018
-
Figure Shikoku Inactivated Vaccines Consumption Share by Types in 2026
-
Table Shikoku Inactivated Vaccines Consumption by End-Users from 2014 to 2026
-
Table Shikoku Inactivated Vaccines Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Inactivated Vaccines Consumption Share by End-Users in 2014
-
Figure Shikoku Inactivated Vaccines Consumption Share by End-Users in 2018
-
Figure Shikoku Inactivated Vaccines Consumption Share by End-Users in 2026
-
Table Kyushu Inactivated Vaccines Consumption by Types from 2014 to 2026
-
Table Kyushu Inactivated Vaccines Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Inactivated Vaccines Consumption Share by Types in 2014
-
Figure Kyushu Inactivated Vaccines Consumption Share by Types in 2018
-
Figure Kyushu Inactivated Vaccines Consumption Share by Types in 2026
-
Table Kyushu Inactivated Vaccines Consumption by End-Users from 2014 to 2026
-
Table Kyushu Inactivated Vaccines Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Inactivated Vaccines Consumption Share by End-Users in 2014
-
Figure Kyushu Inactivated Vaccines Consumption Share by End-Users in 2018
-
Figure Kyushu Inactivated Vaccines Consumption Share by End-Users in 2026
Table Company Profile and Development Status of MedImmune, LLC
Table Sales, Revenue, Sales Price and Gross Margin Analysis of MedImmune, LLC
Figure Sales and Growth Rate Analysis of MedImmune, LLC
Figure Revenue and Market Share Analysis of MedImmune, LLC
Table Product and Service Introduction of MedImmune, LLC
Table Company Profile and Development Status of Merck & Co
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co
Figure Sales and Growth Rate Analysis of Merck & Co
Figure Revenue and Market Share Analysis of Merck & Co
Table Product and Service Introduction of Merck & Co
Table Company Profile and Development Status of India Pvt Ltd (India)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of India Pvt Ltd (India)
Figure Sales and Growth Rate Analysis of India Pvt Ltd (India)
Figure Revenue and Market Share Analysis of India Pvt Ltd (India)
Table Product and Service Introduction of India Pvt Ltd (India)
Table Company Profile and Development Status of Astellas Pharma Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma Inc
Figure Sales and Growth Rate Analysis of Astellas Pharma Inc
Figure Revenue and Market Share Analysis of Astellas Pharma Inc
Table Product and Service Introduction of Astellas Pharma Inc
Table Company Profile and Development Status of Sanofi Pasteur
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi Pasteur
Figure Sales and Growth Rate Analysis of Sanofi Pasteur
Figure Revenue and Market Share Analysis of Sanofi Pasteur
Table Product and Service Introduction of Sanofi Pasteur
Table Company Profile and Development Status of GlaxoSmithKline
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
Figure Revenue and Market Share Analysis of GlaxoSmithKline
Table Product and Service Introduction of GlaxoSmithKline
Table Company Profile and Development Status of Emergent BioSolutions, Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Emergent BioSolutions, Inc
Figure Sales and Growth Rate Analysis of Emergent BioSolutions, Inc
Figure Revenue and Market Share Analysis of Emergent BioSolutions, Inc
Table Product and Service Introduction of Emergent BioSolutions, Inc
Table Company Profile and Development Status of CSL Limited
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL Limited
Figure Sales and Growth Rate Analysis of CSL Limited
Figure Revenue and Market Share Analysis of CSL Limited
Table Product and Service Introduction of CSL Limited
Table Company Profile and Development Status of India Pvt. Ltd. (India)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of India Pvt. Ltd. (India)
Figure Sales and Growth Rate Analysis of India Pvt. Ltd. (India)
Figure Revenue and Market Share Analysis of India Pvt. Ltd. (India)
Table Product and Service Introduction of India Pvt. Ltd. (India)
Table Company Profile and Development Status of Serum Institute
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Serum Institute
Figure Sales and Growth Rate Analysis of Serum Institute
Figure Revenue and Market Share Analysis of Serum Institute
Table Product and Service Introduction of Serum Institute
Table Company Profile and Development Status of Pfizer
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
Figure Sales and Growth Rate Analysis of Pfizer
Figure Revenue and Market Share Analysis of Pfizer
Table Product and Service Introduction of Pfizer
-
